Feeds
672 results total, viewing 1 - 20
Virtual solutions for depression and anxiety can lead to clinically meaningful outcomes, but certain pricing models may increase costs for employers and health plans, according to the Peterson Health … more
GSK drug Nucala has expanded its FDA-approved uses to include maintenance treatment of chronic obstructive pulmonary disease that’s driven by eosinophils, a type of immune cell. The antibody drug … more
Startup finalists competed in four tracks: biopharma; devices and diagnostics; health tech aimed at consumers and self-insured employers; and health tech aimed at payers and providers. Investor … more
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members. more
Researchers think an experimental anti-inflammatory drug for people with multiple sclerosis might help Alzheimer's patients. And they've already tried it on a man named Joe. more
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should be targeted by updated versions of the vaccines. more
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share. more
A new measure making its way through Delaware’s state legislature could change how and where THC-infused beverages are sold. House Bill 98, introduced by Representative Debra Heffernan, proposes … more
The Health Secretary's report blames environmental toxins, ultraprocessed foods and more for the poor state of kids' health in the U.S. more
Children’s HealthWatch is gravely concerned by the House-passed reconciliation bill that threatens to dismantle essential programs like Medicaid and the Supplemental Nutrition Assistance Program … more
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell … more
The Alzheimer’s disease drugs that have reached the market in the past two years are antibodies designed to break up amyloid plaques. Vigil Neuroscience brings to Sanofi a different approach: an … more
Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted … more
Newton Golf Company (NASDAQ: NWTG) is revolutionizing golf performance through its high-quality, custom-fitted shafts engineered to match individual swing dynamics. Recognizing the shaft as the … more
Pre-production gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) has a positive outlook for the precious metals as company officers promote insights to its unique clean … more
NPR interviews Maria Van Kherkove, the infectious disease epidemiologist who is a leader in the World Health Organization. more
In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 (https://ibn.fm/9K5zT). … more
YUYAO, CHINA - Media OutReach Newswire - 22 May 2025 - From May 22 to 25, the fourth China-Central and Eastern European Countries Expo & International Consumer Goods Fair will be held in Ningbo, a … more
Structural batteries that merge structural strength with battery power could open the door to a new age of electric mobility. Lithium-ion batteries are used to power most electric cars due to their … more
Researchers have developed a novel brain tumor test that surgical experts have dubbed a game changer. This is because the test collapses the needed time to obtain an accurate diagnosis to just … more
1 | 2 | 3 | 4 | 5 | 6 | 7 34 | Next »